您的位置: 首页 > 农业专利 > 详情页

ADMINISTRATION D'ARN POUR DÉCLENCHER DE MULTIPLES VOIES IMMUNITAIRES
专利权人:
GlaxoSmithKline Biologicals S.A.
发明人:
申请号:
EP17177123.1
公开号:
EP3243526A1
申请日:
2011.07.06
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
RNA encoding an immunogen is co-delivered to non-immune cells at the site of delivery and also to immune cells which infiltrate the site of delivery. The responses of these two cell types to the same delivered RNA lead to two different effects, which interact to produce a string immune response against the immunogen. The non-immune cells translate the RNA and express the immunogen. Infiltrating immune cells respond to the RNA by expressing type I interferons and pro-inflammatory cytokines which produce a local adjuvant effect which acts on the immunogen-expressing non-immune cells to up-regulate major histocompatibility complex expression, thereby increasing presentation of the protein to T cells. The effects on the immune and non-immune cells can be achieved by a single delivery of a single RNA e.g. by a single injection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充